Piper Sandler Maintains Overweight on Braze, Lowers Price Target to $38
Piper Sandler analyst Brent Bracelin maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $47 to $38.
A Marketing Tech Stock Added WhatsApp. Now They Can’t Be ‘Copied’ Analyst Says
Needham analyst Scott Berg maintained Braze Inc (NASDAQ:BRZE) with a Buy and cut the price target from $70 to $50. Berg attended…
5 Analysts Have This to Say About Braze
Over the past 3 months, 5 analysts have published their opinion on Braze (NASDAQ:BRZE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
$3.8 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
Although US stocks traded mostly lower on Tuesday, there were a few notable insider trades.
$10 Million Bet On NortonLifeLock? 4 Stocks Insiders Are Buying
Although US stocks closed lower on Tuesday, there were a few notable insider trades.
12 Information Technology Stocks Moving In Wednesday’s Pre-Market Session
Gainers
Taoping (NASDAQ:TAOP) stock moved upwards by 12.4% to $0.68 during Wednesday's pre-market session. The company's market cap stands at $10.6 million.
Tesla, Meta, NVIDIA And Other Big Losers From Tuesday
U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session.
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Braze Analysts Hail Its cRPO Momentum While Keeping Their Guard Over Macro Challenges
Braze, Inc (NASDAQ:BRZE) reported Q2 revenue growth of 54.5% year-on-year to $86.1 million, beating the consensus of $81.1 million. Adjusted EPS…